Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
Bexsero incomplete doses; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (a patient who received one men be at 13). The patient did not receive Bexsero. The patient had incomplete course of vaccination (Verbatim: Bexsero incomplete doses). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 10-SEP-2025 The reported wanted to know what to do with a patient who received one Men B at 13 and now (at the time of reporting) was 14. If they should complete the series or wait until 16 and give two doses.